Jun 25, 20192 minLots of Uncertainty in Upcoming GLYC Sickle Cell ReadoutGLYC has what is likely to be a binary event reading out later this year, likely in the next 45 days, with the phase 3 readout of its...
Sep 27, 20232 minBig/Suspected Movers FAQ/User GuideWhat is a Big-Mover™ event? Big-Mover™ events are upcoming high-impact biopharma catalyst events, usually clinical trial read-outs, that...
Aug 28, 20231 minQuarterly Big Mover Biotech Stocks To WatchOur free Big-Mover Report: Listing of 10 of the biggest clinical readouts this quarter Use this info: To update your holdings before a...
Aug 17, 20231 minQ2 2023 Product Revenue AnalysesWe have gone through the Q2 2023 financial reports to analysis each companies product revenue to see: Q2 '23 revenue Q2 '22 revenue Q2...
Aug 15, 20233 minBPIQ Q2 2023 Biotech Hedge Fund (13F) AnalysisLast updated 8/15/23 Summary: Hedge fund holdings can help you discover new investment ideas Get more stock idea and see the full list of...
Aug 7, 20231 minSYFOVRE (APLS) vs. IZERVAY (Astellas)Tough month for APLS • 1st: safety issue surfaces for SYFOVRE ⇨ Retinal Vasculitis • Now: IZERVAY approved early ⇨ Good for AMD patients...
Aug 7, 20231 minBIIB & SAGE: ZuranoloneBig PDUFA from a big collaboration: BIIB & SAGE PDUFA - 8/5/23 - Zuranolone in MDD & PPD Collaboration since 2020… BIIB invested $1.5B in...
Jul 31, 20231 minApellis Pharmaceuticals (APLS)BIOPHARMA STOCK NEWS FLASH APLS provides SYFOVRE safety update Background: SYFOVRE approved by FDA • Feb 2023 • pegcetacoplan injection •...